\begin{table}[hb!]
\begin{center}
\begin{threeparttable}
\begin{tabular}{@{}rccccc@{}}
\multicolumn{1}{l}{} & {\bf \it DmCa\textsubscript{v}3} & {\bf \it RatCa\textsubscript{v}3.1} & {\bf \it Ca\textsubscript{v}3.1} & {\bf \it Ca\textsubscript{v}3.2} & {\bf \it Ca\textsubscript{v}3.3} \\
\multicolumn{1}{l}{{\bf Activation}} & {\bf \it } & {\bf \it } & {\bf \it } & {\bf \it } & {\bf \it } \\ \midrule \addlinespace
V\textsubscript{50} (mV) & \textminus43.3 $\pm$ 1.6 (11) & \textminus38.9 $\pm$ 1.2 (14) & {\bf \textminus40.0 $\pm$ 0.8\cite{park:2006aa}} & \textminus36.2 $\pm$ 0.6\cite{park:2006aa} & \textminus29.1 $\pm$ 1.3\cite{park:2006aa} \\ \addlinespace
{\it $k$} (mV) & 7.7 $\pm$ 1.3 (11) & 6.4 $\pm$ 0.9 (14) & NA & NA & NA \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Inactivation}} &  &  &  &  &  \\ \midrule \addlinespace
V\textsubscript{50} (mV) & \textminus58.0 $\pm$ 0.7 (5) & \textminus61.3 $\pm$ 0.7 (15) & \textminus64.9 $\pm$ 0.7\cite{park:2006aa} & \textminus62.0 $\pm$ 0.9\cite{park:2006aa} & {\bf \textminus55.6 $\pm$ 0.9\cite{park:2006aa}} \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Current kinetics (\textminus20 mV)}} &  &  &  &  &  \\ \midrule \addlinespace
Activation $\tau$ ($\tau$\textsubscript{act}, ms) & 2.2 $\pm$ 0.2 (10) & 1.1 $\pm$ 0.2 (5) & 1.4 $\pm$ 0.1\cite{lee:1999aa} & {\bf 3.2 $\pm$ 0.1\cite{lee:1999aa}} & 22.8 $\pm$ 1.5\cite{lee:1999aa} \\ \addlinespace
Inactviation $\tau$ ($\tau$\textsubscript{inact}, ms) & 23.4 $\pm$ 1.4 & 9.7 $\pm$ 0.9 & 7.2 $\pm$ 0.4\cite{lee:1999aa} & {\bf 11.6 $\pm$ 0.2\cite{lee:1999aa}} & 97.0 $\pm$ 3.8\cite{lee:1999aa} \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Conductance}} &  &  &  &  &  \\ \midrule \addlinespace
I\textsubscript{Ca}/I\textsubscript{Ba} & 0.7 (6) & 1.6 (3) & 1.5\cite{shcheglovitov:2007aa} & 0.8\cite{shcheglovitov:2007aa} & {\bf 0.7\cite{shcheglovitov:2007aa}} \\ \addlinespace \addlinespace
\multicolumn{1}{l}{{\bf Pharmacology}} &  &  &  &  &  \\ \midrule \addlinespace
\multirow{2}{*}{Ni\textsuperscript{2+} (IC\textsubscript{50} $\mu$M)} & \multirow{2}{*}{5.1 (6-12)} & \multirow{2}{*}{276.5 (5-6)} & 167 $\pm$ 15\cite{lee:1999ab} & {\bf 5.7 $\pm$ 0.3\cite{lee:1999ab}} & 87 $\pm$ 7\cite{lee:1999ab} \\ \addlinespace
 &  &  & 250 $\pm$ 22\cite{lee:1999ab}\tnote{a} & 12 $\pm$ 2\cite{lee:1999ab}\tnote{a} & 216 $\pm$ 9\cite{lee:1999ab}\tnote{a}
\end{tabular}
    \begin{tablenotes}
        \begin{flushleft}
        \item[a] Recorded in HEK293 cells
        \end{flushleft}
    \end{tablenotes}
\end{threeparttable}
\end{center}
\newline
\caption{{\bf Comparison of the biophysical properties of DmCa\textsubscript{v}3 and mammalian T-type calcium channels} \newline
V\textsubscript{50}, potential of half maximal activation or inactivation.
$k$, slope factor from the Boltzmann equation.
Number of oocytes is in parentheses.
The measurements reported in the first two columns labeled DmCa\textsubscript{v}3 and RnCa\textsubscript{v}3.1 were obtained in this study, while the final three columns were taken from published reports.
Bold-faced entries in the final three columns denote the mammalian T-type channel properties most closely matching the properties of DmCa\textsubscript{v}3.
NA, not available.}
\label{tab:1}
\end{table}
    
    
    
    
  
  